Skip to main content
SpringerLink
Log in

Micro RNAs: The Future of Idiopathic Pulmonary Fibrosis Therapy

  • Commentary
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Olson, A. L., & Swigris, J. J. (2012). Idiopathic pulmonary fibrosis: diagnosis and epidemiology. Clinics in Chest Medicine, 33(1), 41–50.

    Article  PubMed  Google Scholar 

  2. Ley, B., Collard, H. R., & King, T. E, Jr. (2011). Clinical course and prediction of survival in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 183(4), 431–440.

    Article  PubMed  Google Scholar 

  3. Dakhlallah, D., et al. (2013). Epigenetic regulation of miR-17–92 contributes to the pathogenesis of pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 187(4), 397–405.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Nuovo, G. J., et al. (2009). A methodology for the combined in situ analyses of the precursor and mature forms of microRNAs and correlation with their putative targets. Nature Protocols, 4(1), 107–115.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Cho, J. H., et al. (2011). Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes. BMC Medical Genomics, 4, 8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Ventura, A., et al. (2008). Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell, 132(5), 875–886.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Lu, Y., et al. (2007). Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Development Biology, 310(2), 442–453.

    Article  CAS  Google Scholar 

  8. Liu, G., et al. (2010). miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. Journal of Experimental Medicine, 207(8), 1589–1597.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Bechtel, W., et al. (2010). Methylation determines fibroblast activation and fibrogenesis in the kidney. Nature Medicine, 16(5), 544–550.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

NK was funded by the American Heart Association National Scientist Development Grant 09SDG2260957 and National Institutes of Health R01 HL105932 and the Joy McCann Culverhouse Endowment to the Division of Allergy and Immunology.

Author information

Authors and Affiliations

  1. Division of Allergy and Immunology, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd., MDC 19, Tampa, FL, 33612, USA

    Tara Vinyette Saco, Prasanna Tamarapu Parthasarathy, Young Cho, Richard Lockey & Narasaiah Kolliputi

Authors
  1. Tara Vinyette Saco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prasanna Tamarapu Parthasarathy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Young Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Richard Lockey
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Narasaiah Kolliputi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Narasaiah Kolliputi.

Additional information

A commentary on Dakhlallah, D., et al., Epigenetic regulation of miR-17–92 contributes to the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med, 2013. 187(4): p. 397–405.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saco, T.V., Parthasarathy, P.T., Cho, Y. et al. Micro RNAs: The Future of Idiopathic Pulmonary Fibrosis Therapy. Cell Biochem Biophys 71, 509–511 (2015). https://doi.org/10.1007/s12013-014-0217-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-014-0217-9

Keywords

Search

Navigation